For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
College of GPs award funding for research on parental leave
College of GPs award funding for research on parental leave

The Royal New Zealand College of General Practitioners has awarded $5,000 to research that benefits general practice. The funding is awarded three times a year by the Research and Education Committee (REC).
The College received five applications for the final funding round of 2021. There was one successful applicant:
Dr Rachel Roskvist | Auckland
Research title: The parental leave experiences of New Zealand General Practitioners
Amount awarded: $5,000
Summary: This research aims to describe the experiences, challenges and barriers of NZ GPs taking and returning from parental leave and using these experiences to formulate recommendations to support them. The data collected will be useful for future workforce planning, to identify any difficulties and gaps with the process, and to characterise an issue that largely impacts women, and has strong relevance to Māori and Pasifika.
The funding rounds for 2022 are available on the College website.